Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant Patients
Clinical trial NCT00295607 · COMPLETED
Trial details
- NCT number
- NCT00295607
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2008-06-01
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.